成年镰状细胞病患者肾血流模式与肾血管参数的表现
本研究纳入65例无实验室肾损害证据的稳定期成年镰状细胞病患者(50例HbSS、12例HbSβ0、3例HbSD)与30例年龄性别匹配健康对照,用超声评估肾脏长度、回声、血流参数。患者组肾长度、皮质厚度、皮质回声及肾外PSV、肾内RI和AT均高于对照组(P < .05),提示这些超声改变可作为早期肾受累指标。
要点
- 成年镰状细胞病患者即使无实验室肾损害证据,也可出现肾脏长度增加和皮质回声轻度弥漫性增高。
- 患者组肾外峰值收缩速度、肾内阻力指数和加速时间均高于健康对照,可能反映早期肾血流动力学改变。
- 患者组RI、AT与PSV之间无显著相关性,提示这些参数需结合评估而非相互推断。
核心结论
- 肾脏长度增加、皮质回声增高以及PSV、RI和AT值升高可作为无肾损害的成年镰状细胞病患者的早期超声改变。
研究设计与样本
- 研究纳入65例稳定期成年镰状细胞病患者(50例血红蛋白SS型、12例HbSβ0型、3例HbSD型)和30例年龄及性别匹配的健康对照。
- 使用1-5-MHz凸阵探头经腹部超声获取肾脏长度、回声模式、峰值收缩速度、舒张末期速度、肾-主动脉比值、阻力指数、加速时间和肾静脉速度。
关键影像表现/征象
- 患者组肾长度和皮质厚度最高均值分别为11.78 ± 1.30 cm和1.86 ± 0.41 cm,对照组分别为11.27 ± 0.77 cm和1.78 ± 0.28 cm,患者组显著高于对照组(P < .05)。
- 59例(90.8%)患者表现为皮质回声轻度弥漫性增高,而肾皮质厚度保留。
- 患者组肾外PSV最高均值为138.46 ± 56.32 cm/s,对照组为101.75 ± 31.48 cm/s(P < .05)。
- 患者组肾内RI和AT最高均值分别为0.69 ± 0.07和0.06 ± 0.02秒,对照组分别为0.63 ± 0.05和0.04 ± 0.01秒(P < .05)。
诊断标准与关键数值
- 患者组与对照组肾长度最高均值分别为11.78 ± 1.30 cm和11.27 ± 0.77 cm(P < .05)。
- 患者组与对照组皮质厚度最高均值分别为1.86 ± 0.41 cm和1.78 ± 0.28 cm(P < .05)。
- 患者组与对照组肾外PSV最高均值分别为138.46 ± 56.32 cm/s和101.75 ± 31.48 cm/s(P < .05)。
- 患者组与对照组肾内RI最高均值分别为0.69 ± 0.07和0.63 ± 0.05(P < .05)。
- 患者组与对照组肾内AT最高均值分别为0.06 ± 0.02秒和0.04 ± 0.01秒(P < .05)。
临床应用与阅片要点
- 对无实验室肾损害证据的成年镰状细胞病患者,超声检查可关注肾脏长度、皮质回声及肾血流参数(PSV、RI、AT)的早期变化。
- 患者组RI、AT与PSV之间无显著相关性(P > .05),解读这些参数时不宜相互替代或简单推断。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate renal blood flow patterns and renovascular parameters in adult patients with sickle cell disease (SCD) without laboratory evidence of renal impairment.
METHODS: Sixty-five steady-state adult patients with SCD (50 hemoglobin SS [HbSS], 12 HbSβ0 , and 3 HbSD) and 30 age- and sex-matched healthy controls were studied. The kidney length, echo pattern, peak systolic velocity (PSV), end-diastolic velocity, renal-to-aortic ratio, resistive index (RI), acceleration time (AT), and renal vein velocity were acquired, recorded, and analyzed with a 1-5-MHz curvilinear transducer through the abdomen.
RESULTS: The mean age ± SD of the patients with SCD was 32.89 ± 13.89 years. The highest means for the ultrasound-measured renal length and cortical thickness in the SCD and control groups were 11.78 ± 1.30 and 11.27 ± 0.77 cm and 1.86 ± 0.41 and 1.78 ± 0.28 cm, respectively. The figures were significantly higher in the SCD group than the control group (P < .05). Fifty-nine (90.8%) patients had a mild diffuse increase in cortical echogenicity with preserved renal cortical thickness. The highest mean extrarenal PSVs in the SCD and control groups were 138.46 ± 56.32 and 101.75 ± 31.48 cm/s (P < .05). However, the highest intrarenal RI and AT in SCD and control groups were 0.69 ± 0.07 and 0.06 ± 0.02 seconds and 0.63 ± 0.05 and 0.04 ± 0.01 seconds (P < .05). There was no significant correlation between the RI, AT, and PSV among the patients with SCD (P > .05).
CONCLUSIONS: Increased renal length and cortical echogenicity with elevated PSV, RI, and AT values can serve as early ultrasound changes in adult patients with SCD without renal impairment.
引用
- Asbeutah AM, Adekile A, AlMajran AA, et al. Pattern of Renal Blood Flow and Renovascular Parameters in Adult Patients With Sickle Cell Disease. J Ultrasound Med. 2019. PMID: 31663639. doi:10.1002/jum.15158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。